Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Rothman currently holds 163,810 shares of Bruker Cellular Analysis, Inc. (CELL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Rothman has been a net seller of CELL stock. They have purchased $103.7K and sold $13.0M worth of shares.
James Rothman's most recent insider trade was on Oct 2, 2023, when they sold 118,810 shares at $0.00 per share.
James Rothman serves as Executive at Bruker Cellular Analysis, Inc. (CELL). They have executed 19 insider transactions totaling $13.1M over their tenure at the company.
James Rothman holds the position of Executive at Bruker Cellular Analysis, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James Rothman has shown a selling trading pattern, with $103.7K in total purchases and $13.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Rothman was on Mar 5, 2021, when they sold $7.4M worth of BLI shares. This transaction involved 140,000 shares at $52.75 per share.
James Rothman currently owns 163,810 shares of Bruker Cellular Analysis, Inc. (CELL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Rothman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Rothman has 19 Form 4 filings on record as an insider at Bruker Cellular Analysis, Inc..
Set alerts for James Rothman and 40,000+ other insiders.